Patricia Christian is a distinguished global regulatory executive with a proven track record in steering medical device regulatory, clinical, and quality organizations toward exceptional business growth. As a Board Member of JFK Health System, she has played a pivotal role in shaping the long-term strategy...
Patricia Christian is a distinguished global regulatory executive with a proven track record in steering medical device regulatory, clinical, and quality organizations toward exceptional business growth. As a Board Member of JFK Health System, she has played a pivotal role in shaping the long-term strategy of the organization, particularly through her leadership in the selection of Hackensack Meridian Health as a strategic acquisition partner. This decision, which culminated in a successful acquisition on January 1, 2018, underscores her expertise in mergers and acquisitions (M&A) and her deep understanding of the healthcare landscape.
In her current role, Patricia actively engages in governance and strategic planning, serving on key committees such as the Strategic Planning Committee, Joint Conference, and Executive Compensation Committee. Her collaborative approach fosters an environment where innovative ideas can flourish, ensuring that JFK Health System remains competitive and viable in an ever-evolving industry. Patricia’s extensive knowledge of regulatory affairs, particularly in navigating FDA regulations and ISO 13485 standards, has been instrumental in guiding the organization through complex regulatory submissions and compliance challenges.
Her commitment to excellence is evident in her ability to align organizational goals with regulatory requirements, ultimately driving the successful launch of new medical devices and enhancing patient care. With a keen focus on design control and corrective and preventive actions (CAPA), Patricia continues to champion quality and safety in healthcare delivery. Her strategic vision and hands-on leadership style not only enhance JFK Health System’s operational effectiveness but also position it for sustained growth and innovation in the medical device sector.
